[ Pharmaceutical Sciences Asia - ONLINE ]

E-ISSN 2586-8470

[ Journal Abbreviation: Pharm.Sci.Asia ]

FORMER NAME "Mahidol University Journal of Pharmaceutical Sciences"

Published Since 1974

Abstracts

DOI: 10.29090/psa.2020.02.020.0026

Pharm Sci Asia 2020; 47(2), 97-103

Pharmacological treatment for the Novel Coronavirus Disease 2019 (COVID-19 Infection)

Nattapong Tidwong^{1, 2}*, Preecha Montakantikul², Weerawat Manosuthi³

¹ Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand
² Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
³ Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand

As of March 22, 2020, a total of 292,142 confirmed coronavirus disease 2019 (COVID-19) cases have been reported globally. Although there are currently no specific antiviral agents but all coronaviruses shared similar key elements of target for currently approved antiviral or new drug development. Several agents might be considered as a possible treatment based on the efficacy in SARS and MERS.

Keyword:

Novel coronavirus; COVID-19; SARS-CoV-2; Antivirals

Download full paper (PDF File size: 350.18 KB.)

Vol.47

No.4

October - December 2020

See other volume

Vol.47

No.3

July - September 2020

See other volume

Vol.47

No.2

April - June 2020

See other volume

Vol.47

No.1

January - March 2020

See other volume

	Home
	Aims and Scope
	Editorial Board
	Publication Ethics
	Instruction to Authors
	Announcement
	All Volumes & Issues
	Submit Online
	Contact us

	Search

	Faculty of Pharmacy Mahidol University
	Mahidol University

Member's menu

You're now loging on with following account:
Guest (unknown)

Please Sign in or Register

Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0

We use Cookies

This site uses cookies to personalise your experience and analyse site traffic. By Clicking ACCEPT or continuing to browse the site you are agreeing to our use of cookies.